levodopa has been researched along with amphetamine in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 94 (53.41) | 18.7374 |
| 1990's | 26 (14.77) | 18.2507 |
| 2000's | 29 (16.48) | 29.6817 |
| 2010's | 26 (14.77) | 24.3611 |
| 2020's | 1 (0.57) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cox, B; Kastin, AJ; Schnieden, H | 1 |
| Renshaw, DC | 1 |
| Allikmets, LH; Zharkovsky, AM | 1 |
| Carolei, A; Del Castillo, G | 1 |
| Desiles, M; Puech, AJ; Rips, R | 1 |
| Ahlenius, S; Berggren, U; Engel, J; Tallstedt, L | 1 |
| Crossman, AR; Sambrook, MA; Slater, P | 1 |
| Baran, L; Palider, W; Przegaliński, E; Siwanowicz, J | 1 |
| Fujimura, Y; Ikeda, Y; Iwasaki, T; Koide, T; Matsushita, H; Nagashima, R; Shindo, M; Shiraki, Y; Suzuki, S; Takano, N | 1 |
| Nistico', G; Stephenson, JD | 1 |
| Klawans, HL; Weiner, WJ | 1 |
| Lamprecht, F | 1 |
| Poshivalov, VP | 1 |
| Nahorski, SR; Rogers, KJ | 1 |
| Ljungberg, T; Ungerstedt, U | 1 |
| Dinnendahl, V; Gumulka, SW; Peters, HD; Schönhöfer, PS | 1 |
| Snodgrass, SR; Uretsky, NJ | 1 |
| Bédard, P; Dankova, J; Langelier, P; Poirier, LJ | 1 |
| Colpaert, FC; Lal, H; Niemegeers, C; Wauquier, A | 1 |
| Baldessarini, RJ; Harris, JE | 1 |
| Laverty, R | 1 |
| Lazarova, M; Roussinov, K | 2 |
| Agnoli, A; Squitieri, G | 1 |
| Barczyńska, J; Felsztyńska, J; Kedzierska, L; Wilimowski, M; Witkowska, M; Wojewodzki, W | 2 |
| Podol'skiĭ, IIa | 1 |
| Kellams, JJ; Lemberger, L; Rowe, H; Small, JG | 1 |
| Bhargava, HN | 1 |
| Uemura, H | 1 |
| Oppenheim, R; Pittman, R; Ramakrishna, T | 1 |
| Pepeu, G | 1 |
| Barry, VC; Klawans, HL | 1 |
| Poirier, LJ | 1 |
| Breese, GR; Cooper, BR; Cott, JM; Jahnke, GD; Lipton, MA; Plotnikoff, NP; Prange, AJ; Wilson, IC | 1 |
| Bartholini, G; Haefely, W; Pletscher, A | 1 |
| Cuparencu, B; Sandor, V | 1 |
| Ahlenius, S; Carlsson, SG | 1 |
| Angrist, B; Gershon, S | 1 |
| Debono, AG; Jenner, P; Parkes, JD; Walters, J | 1 |
| Rolls, ET; Shaw, SG | 1 |
| Johnson, AM; Loew, DM; Vigouret, JM | 1 |
| Lapin, IP; Patkina, NA | 1 |
| Fielding, S; Lal, H; Marky, M | 1 |
| Andreeva, NI; Mashkovskiĭ, MD | 1 |
| Bergen, D; Goetz, C; Klawans, HL | 1 |
| Sassin, JF | 1 |
| Asselman, P; Bovill, KT; Marsden, CD; Parkes, JD; Phipps, JA; Rose, P; Tarsy, D | 1 |
| Klawans, HL; Margolin, DI | 1 |
| Strömberg, U; Svensson, TH | 1 |
| Colpaert, FC; Laduron, P; Lal, H | 1 |
| Crossett, P; Dana, N; Klawans, HL | 1 |
| Buckett, WR; Shaw, JS | 1 |
| Jenner, P; Marsden, CD | 1 |
| Monti, JM; Ruiz, M | 1 |
| Agnoli, A; Carolei, A; Cerbo, R; Meco, G; Ruggieri, S; Zamponi, A | 1 |
| Dandiya, PC; Kulkarni, SK | 1 |
| Luchins, D | 1 |
| Dluzen, DE; Kratko, FT | 1 |
| Sgaragli, GP; Tipton, KF; Valoti, M | 1 |
| Männistö, PT; Törnwall, M | 2 |
| Collier, TJ; Sladek, JR; Steece-Collier, K; Yurek, DM | 1 |
| Bernardi, G; Calabresi, P; Mercuri, NB | 1 |
| Dluzen, DE; McDermott, JL | 1 |
| Davis, A; Jenner, P; Marsden, CD | 1 |
| el-Sawaf, HA; Puri, VN; Rao, KV | 1 |
| Dluzen, DE; McDermott, JL; Ramirez, VD | 1 |
| Blunt, SB; Jenner, P; Marsden, CD | 1 |
| Dimpfel, W; Spüler, M | 1 |
| Dovedova, EL; Jankovic, B; Popova, NS; Veskova, R | 1 |
| Borisov, MM | 1 |
| Fitten, J; Kling, AS; Kodama, CK; Menon, MK | 1 |
| Kuhr, WG; May, LJ; Wightman, RM | 1 |
| Herrera-Marschitz, M; Ungerstedt, U; Zetterström, T | 1 |
| Bretton, C; Hof, P; Ofori, S; Schorderet, M | 1 |
| Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
| Boismare, F; Daoust, M; Moore, N; Saligaut, C | 1 |
| Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
| Bhalla, S; Mehta, VL; Wafai, ZA | 1 |
| Lyman, CP; O'Brien, RC | 1 |
| Bhakthavatsalam, P; Ghosh, MN; Kamatchi, GL | 1 |
| Diaz-Veliz, G; Mora, S | 1 |
| Herbster, G; Koller, WC | 1 |
| D'Antona, N; De Leo, V; Genazzani, AR; Gioffrè, WR; Mazzullo, G; Petraglia, F; Sardelli, S | 1 |
| Bédard, P; Boucher, R; Langelier, P; Larochelle, L; Parent, A; Poirier, LJ; Roberge, AG | 1 |
| Ginestet, D | 1 |
| Colpaert, FC; Lal, H | 1 |
| Ljungberg, T; Steg, G; Ungerstedt, U | 1 |
| Bianchine, JR; Sunyapridakul, L | 1 |
| Rogóz, Z; Skuza, G; Sowińska, H | 2 |
| Carvey, P; Goetz, CG; Klawans, HL | 1 |
| Brown, JW; Kramarcy, NR; Thurmond, JB | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| Carlson, GM; Gianutsos, G; Godfrey, JG | 1 |
| Berggren, U; Engel, J | 1 |
| Bianchine, JR; Schwarz, RD; Uretsky, NJ | 1 |
| Elsworth, JD; Lees, AJ; Sandler, M; Stern, GM; Ward, C | 1 |
| Hefti, F; Melamed, E; Sahakian, BJ; Wurtman, RJ | 1 |
| Dawbarn, D; O'Shaughnessy, C; Pycock, C | 1 |
| Heffner, TG; Stricker, EM; Zigmond, MJ | 1 |
| Altar, A; Goldwag, D; Lytle, LD; Terry, RL | 1 |
| Hefti, F; Melamed, E | 1 |
| Korányi, L; Phelps, CP; Tamásy, V | 1 |
| Iakimovskiĭ, AF | 1 |
| Bédard, PJ; Côté, PY; Grégoire, L; Parent, A; Roy, E | 1 |
| Ossowska, K | 1 |
| Chase, TN; Engber, TM; Kask, AM; Papa, SM | 1 |
| Dluzen, DE; Liu, B | 1 |
| Gash, DM; Sakai, K | 1 |
| Bankiewicz, KS; de Jesus, S; Sheng, J; Takubo, H; Thomas, J; Wang, J | 1 |
| Carruba, MO; da Prada, M; Imhof, R; Nisoli, E; Scherschlicht, R; Tonello, C | 1 |
| Boja, JW; Ehlers, MD; Kim, SE; Kuhar, MJ; Scheffel, U; Steinert, C | 1 |
| De Souza Silva, MA; Häcker, R; Huston, JP; Mattern, C; Nogueira, PJ; Schwarting, RK | 1 |
| Carta, G; Casu, MA; Gessa, GL; Imperato, A; Mascia, MS; Obinu, MC | 1 |
| Bjurling, P; Fasth, KJ; Hartvig, P; Långström, B; Tedroff, J; Torstenson, R; Watanabe, Y | 1 |
| Agid, Y; Dziewczapolski, G; García, MC; Gershanik, O; Menalled, LB; Murer, MG; Raisman-Vozari, R | 1 |
| Busel, BI; Sanzharovsky, AV; Storozhuk, VM | 1 |
| Damhaut, P; Dethy, S; Goldman, S; Laute, MA | 1 |
| McGeer, EG; Stoessl, AJ; Van Kampen, JM | 1 |
| Cross, AJ; Georger, M; Howell, A; Hudzik, TJ | 1 |
| Campbell, JM; Davies, RW; Favor, G; Gilmore, DP; Growney, CA; Kennedy, AK; Payne, AP; Russell, D; Stone, TW | 1 |
| Metz, GA; Whishaw, IQ | 1 |
| Morikawa, H; Paladini, CA; Palmiter, RD; Robinson, S; Williams, JT | 1 |
| Gong, LW; Khanna, B; Lindau, M; Mosharov, EV; Sulzer, D | 1 |
| Albin, RL; Desmond, TJ; Frey, KA; Kemmerer, ES; Kilbourn, MR | 1 |
| Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O | 1 |
| Bastia, E; Chen, JF; Fredduzzi, S; Moratalla, R; Ongini, E; Schwarzschild, MA; Yu, L | 1 |
| Schmidt, WJ; Srinivasan, J | 1 |
| Abdallah, L; Cannon, CM; During, MJ; Palmiter, RD; Tecott, LH | 1 |
| Hnasko, TS; Kremer, EJ; Palmiter, RD; Robinson, S; Sotak, BN | 1 |
| Benabid, AL; Berger, F; Buggia, V; Gilbert, F; Lévesque, D; Sgambato-Faure, V | 1 |
| Brundin, P; Cenci, MA; Lane, EL; Winkler, C | 1 |
| Bernardi, G; Federici, M; Geracitano, R; Mercuri, NB | 1 |
| Belknap, JK; Johnson, SW; Kozell, LB; Munhall, AC; Putterman, DB | 1 |
| Juckel, G; Klein, J; Kupsch, A; Lee, T; Morgenstern, R; Mundt, A; Petrus, D; von Rumohr, A; Winter, C | 1 |
| Barker, RA; Kuan, WL; Zhao, JW | 1 |
| Berger, SP; Brudney, EG; Johnson, SW; Meshul, CK; Paquette, MA; Putterman, DB | 1 |
| Gerfen, CR; Paletzki, R; Worley, P | 1 |
| Ferrario, JE; Gershanik, OS; Larramendy, C; Murer, MG; Saborido, MD; Taravini, IR | 1 |
| Collier, TJ; Freeman, TB; McGuire, SO; Meredith, G; Soderstrom, KE; Sortwell, CE; Steece-Collier, K; Wu, Q | 1 |
| Brundin, P; Cenci, MA; Lane, EL; Soulet, D; Vercammen, L | 1 |
| Antonelli, T; Cassano, T; Cuomo, V; Dipasquale, P; Ferraro, L; Gaetani, S; Giuffrida, A; Laconca, L; Macheda, T; Morgese, MG | 1 |
| Brundin, P; Cenci, MA; Lane, EL | 1 |
| Brundin, P; Cenci, MA; Lane, EL; Vercammen, L | 1 |
| García-Gutiérrez, MS; Ledent, C; Leiva, C; Leza, JC; Manzanares, J; Molina, JA; Pérez-Nievas, BG; Pérez-Rial, S | 1 |
| Hondebrink, L; Meulenbelt, J; Timmerman, JG; van den Berg, M; Westerink, RH | 1 |
| Bordia, T; Campos, C; McIntosh, JM; Quik, M | 1 |
| Moghaddam, B; Pehrson, AL | 1 |
| Gevorkian, R; Krstenansky, JL; Leitzke, R; Saldivar, A; Shi, WX; Xu, D | 1 |
| Aristieta, A; Cenci, MA; Miguelez, C; Ugedo, L | 1 |
| Chao, OY; Huston, JP; Mattern, C; Nikolaus, S; Pum, ME; Ruocco, LA; Silva, AM; Wessler, J | 1 |
| Chao, OY; Huston, JP; Li, JS; Pum, ME | 1 |
| Björklund, A; Decressac, M; Lundblad, M; Mattsson, B; Weikop, P | 1 |
| Björklund, A; Carta, M; Shin, E; Tronci, E | 1 |
| Björklund, A; Carta, M; Garcia, J; Shin, E; Winkler, C | 1 |
| Bezard, E; Björklund, A; Carta, M; Li, Q; Pioli, EY; Porras, G; Tronci, E | 1 |
| Andrews, AM; Bressler, AJ; Cans, AS; Ewing, AG; Heien, ML; Omiatek, DM | 1 |
| Magyar, K; Szökő, E; Tábi, T; Vécsei, L | 1 |
| Dunnett, SB; Heuer, A; Klein, A; Lane, EL; Smith, GA; Vinh, NN | 1 |
| Björklund, A; Carta, M; Fidalgo, C; Lisci, C; Shin, E; Stancampiano, R; Tronci, E | 1 |
| Hagiwara, M; Kasahata, N; Kato, H; Nakamura, A; Uchihara, T | 1 |
| Björklund, A; Carta, M; Devoto, P; Rogers, JT; Shin, E | 1 |
| Collier, TJ; Gebremedhin, KG; O'Malley, J; Paumier, KL; Rademacher, DJ; Sisson, KA; Sortwell, CE; Stancati, JA; Steece-Collier, K | 1 |
| Carlsson, T; Depboylu, C; Höglinger, GU; Keber, U; Klietz, M; Oertel, WH; Schäfer, MK; Weihe, E | 1 |
| Atcherley, CW; Burrell, MH; Heien, ML; Lipski, J | 1 |
| Atlas, D | 1 |
| Amalric, M; Beurrier, C; Camon, J; Guiraudie-Capraz, G; Kerkerian-Le Goff, L; Liberge, M; Maurice, N; Ztaou, S | 1 |
| Behl, B; Bespalov, A; Janenaite, E; Vengeliene, V | 1 |
| Hänninen, R; Koski, SK; Leino, S; Rannanpää, S; Salminen, O; Tapanainen, T | 1 |
| Denibaud, AS; Drieu La Rochelle, C; Loiodice, S; Méot, B; Montagne, P; Rion, B; Viel, R; Wing Young, H | 1 |
| Cheung, PY; Freestone, PS; Jabed, A; Kalligappa, PK; Karunasinghe, RN; Lipski, J; Lloyd, JT; Todd, KL; Vlajkovic, SM; Yee, AG | 1 |
15 review(s) available for levodopa and amphetamine
| Article | Year |
|---|---|
[Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Levodopa; Lithium; Neurotransmitter Agents; Phenothiazines; Sympatholytics; Tetrabenazine | 1979 |
Dopaminergic mechanisms and stereotyped behaviour in birds.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Birds; Brain Chemistry; Corpus Striatum; Dopamine; Humans; Levodopa; Putamen; Receptors, Dopamine; Stereotyped Behavior; Thyrotropin-Releasing Hormone | 1979 |
The pharmacology of choreatic movement disorders.
Topics: Acetylcholine; Acute Disease; Amphetamine; Chorea; Dopamine; gamma-Aminobutyric Acid; Hepatolenticular Degeneration; Humans; Huntington Disease; Hyperthyroidism; Levodopa; Lupus Erythematosus, Systemic; Movement Disorders; Serotonin | 1976 |
Epilepsy and schizophrenia: a neurochemical bridge.
Topics: Amphetamine; Anticonvulsants; Brain; Butyrophenones; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Epilepsy; Humans; Huntington Disease; Levodopa; Neurocognitive Disorders; Phenothiazines; Phenytoin; Receptors, Dopamine; Schizophrenia | 1977 |
Dopaminergic agents and circling behaviour.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Cyclic AMP; Dopamine; Levodopa; Limbic System; Motor Activity; Norepinephrine; Receptors, Dopamine; Serotonin; Substantia Nigra | 1978 |
On the roles of dopamine and noradrenaline in animal behaviour.
Topics: Adrenergic alpha-Antagonists; Aggression; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature Regulation; Cats; Clonidine; Conditioning, Operant; Dopamine; Drinking Behavior; Enzyme Inhibitors; Feeding Behavior; Haplorhini; Humans; Levodopa; Motor Activity; Norepinephrine; Rage; Rats; Self Stimulation; Stereotyped Behavior; Stress, Psychological | 1975 |
[Memory, biochemical and pharmacological problems].
Topics: Amantadine; Amphetamine; Brain; Catecholamines; Humans; Levodopa; Memory, Short-Term; Paired-Associate Learning; Physostigmine; Reserpine | 1977 |
On the role of dopamine in the pathophysiology of anorexia nervosa.
Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness | 1976 |
Monoaminergic drugs: general pharmacology.
Topics: Absorption; Amantadine; Amphetamine; Animals; Apomorphine; Brain; Catecholamines; Cats; Cattle; Deamination; Decarboxylation; Dogs; Half-Life; Haplorhini; Humans; Hydroxylation; Kinetics; Levodopa; Methylation; Mice; Rats | 1976 |
Drug-induced dyskinesia in monkeys.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Azides; Carbachol; Caudate Nucleus; Chlorpromazine; Disease Models, Animal; Dronabinol; Hydroxydopamines; Levodopa; Movement Disorders; Phenothiazines; Primates; Stereotaxic Techniques; Substantia Nigra; Tegmentum Mesencephali | 1975 |
[Role of the catecholaminergic system of the brain in addiction to alcohol (review)].
Topics: Acetaldehyde; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcohol Deterrents; Alcoholism; Amphetamine; Animals; Brain; Brain Chemistry; Catecholamines; Cholinergic Fibers; Cricetinae; Dopamine; Ethanol; Humans; Hydroxydopamines; Hypothalamus; Isoquinolines; Levodopa; Mice; Norepinephrine; Oxidopamine; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Catecholamine; Serotonin; Synaptic Transmission | 1985 |
Individualization of levodopa therapy.
Topics: Amantadine; Amphetamine; Anesthetics; Animals; Antihypertensive Agents; Apomorphine; Arrhythmias, Cardiac; Carbidopa; Depression, Chemical; Diet; Disulfiram; Drug Interactions; Drug Therapy, Combination; Endocrine Glands; Glaucoma; Humans; Hydrogen-Ion Concentration; Levodopa; Mice; Parasympatholytics; Parkinson Disease; Stomach | 1974 |
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Topics: Age Factors; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Combinations; Drug Interactions; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Haplorhini; Humans; Levodopa; Lithium; Male; Parasympatholytics; Rats; Receptors, Dopamine; Stereotyped Behavior | 1983 |
The role of excitatory amino acids in experimental models of Parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease Models, Animal; Excitatory Amino Acids; Levodopa; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats | 1994 |
On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons.
Topics: Amphetamine; Animals; Antiparkinson Agents; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Neurons; Psychotropic Drugs; Rats | 2006 |
2 trial(s) available for levodopa and amphetamine
| Article | Year |
|---|---|
Amphetamines in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Amphetamine; Clinical Trials as Topic; Female; Humans; Isomerism; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Parkinson Disease, Postencephalitic; Posture; Structure-Activity Relationship; Tremor | 1975 |
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.
Topics: Amphetamine; Carbidopa; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Nomifensine; Postpartum Period; Pregnancy; Prolactin; Receptors, Dopamine | 1987 |
159 other study(ies) available for levodopa and amphetamine
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Brain; Dopamine; Female; Humans; Levodopa; Mice; Motor Activity; MSH Release-Inhibiting Hormone; Rats; Receptors, Drug; Stereotyped Behavior; Time Factors | 1976 |
Sex and drugs.
Topics: Amphetamine; Antidepressive Agents; Antihypertensive Agents; Aphrodisiacs; Cannabis; Cocaine; Cyproterone; Ethanol; Hallucinogens; Histamine H1 Antagonists; Hormones; Humans; Hypnotics and Sedatives; Levodopa; Lithium; Parasympatholytics; Sexual Behavior; Tranquilizing Agents | 1978 |
Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems.
Topics: Adrenergic alpha-Agonists; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Dopamine; Exploratory Behavior; Levodopa; Male; Motor Activity; Rats; Serotonin; Tryptophan | 1978 |
Is a dopaminergic system involved in thyrotropin releasing hormone induced hyperthermia and in its potentiation by amphetamine?
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Dopamine; Dopamine Agents; Female; Fever; Haloperidol; Levodopa; Methyltyrosines; Mice; Neurotransmitter Agents; p-Chloroamphetamine; Pimozide; Thyrotropin-Releasing Hormone | 1979 |
The effect of lithium on amphetamine-induced locomotor stimulation.
Topics: Amphetamine; Animals; Apomorphine; Clonidine; Drug Interactions; Female; Levodopa; Lithium; Methyltyrosines; Mice; Motor Activity; Reserpine; Time Factors | 1978 |
Experimental torticollis in the marmoset produced by injection of 6-hydroxydopamine into the ascending nigrostriatal pathway.
Topics: Amphetamine; Animals; Apomorphine; Benserazide; Callitrichinae; Disease Models, Animal; Drug Therapy, Combination; Haloperidol; Haplorhini; Hydroxydopamines; Hypothalamus; Levodopa; Locus Coeruleus; Male; Torticollis | 1979 |
The central action of pizotifen.
Topics: Amphetamine; Animals; Antidepressive Agents; Body Temperature; Levodopa; Lysergic Acid Diethylamide; Male; Mice; Motor Activity; Nialamide; Pizotyline; Rabbits; Rats; Reflex; Thiophenes; Time Factors | 1979 |
Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
Topics: Acetylcholine; Amphetamine; Animals; Antidepressive Agents; Barbiturates; Behavior, Animal; Biogenic Amines; Blood Pressure; Brain Chemistry; Catecholamines; Cats; Dogs; Electroencephalography; Female; Guinea Pigs; Haplorhini; In Vitro Techniques; Indazoles; Levodopa; Macaca fascicularis; Male; Mice; Muscle Contraction; Muscle, Smooth; Physostigmine; Pyrazoles; Rabbits; Rats; Reserpine; Tremorine | 1979 |
[Analysis of the effect of phenamine, L-DOPA and parachlorophenylalanine on the zoo-social behavior of isolated mice].
Topics: Amphetamine; Animals; Behavior, Animal; Fenclonine; Levodopa; Male; Mice; Social Behavior; Social Isolation | 1979 |
The role of catecholamines in the action of amphetamine and L-DOPA on cerebral energy metabolism.
Topics: Adenosine Triphosphate; Amphetamine; Animals; Brain; Cyclic AMP; Energy Metabolism; Glucose; Glycogen; Humans; Hydroxydopamines; Lactates; Levodopa; Malates; Male; Phosphocreatine; Pimozide; Rats; Stereotyped Behavior; Stimulation, Chemical; Temperature | 1975 |
Automatic registration of behaviour related to dopamine and noradrenaline transmission.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine; Dose-Response Relationship, Drug; Isotonic Solutions; Levodopa; Male; Methods; Motor Activity; Norepinephrine; Phenoxybenzamine; Rats; Synaptic Transmission | 1976 |
Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Benserazide; Brain; Cerebellum; Cyclic AMP; Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoquinolines; Levodopa; Male; Mice; Nucleotides, Cyclic; Stereotyped Behavior | 1976 |
Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices.
Topics: Amphetamine; Animals; Benserazide; Brocresine; Bucladesine; Calcium; Carboxy-Lyases; Catecholamines; Corpus Striatum; Dopamine; Drug Interactions; In Vitro Techniques; Levodopa; Male; Phosphodiesterase Inhibitors; Potassium; Rats; Reserpine; Stimulation, Chemical; Xanthines | 1977 |
Reversal by a central antiacetylcholine drug of pimozide-induced inhibition of mouse-jumping in amphetamine-dopa treated mice.
Topics: Acetylcholine; Amphetamine; Animals; Dexetimide; Levodopa; Male; Mice; Motor Activity; Pimozide; Piperidines; Time Factors | 1975 |
Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum.
Topics: Amphetamine; Animals; Corpus Striatum; In Vitro Techniques; Levodopa; Male; Nerve Endings; Rats; Receptors, Drug; Synaptosomes; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 1975 |
On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Apomorphine; Dopamine; Levodopa; Male; Mice; Pentylenetetrazole; Seizures; Serotonin | 1979 |
Central action of new imido derivatives of succinic acid.
Topics: Amphetamine; Analgesics; Animals; Brain; Chloral Hydrate; Drug Synergism; Female; Hexobarbital; Levodopa; Male; Mice; Movement; Reserpine; Seizures; Sleep; Structure-Activity Relationship; Succinimides | 1979 |
Central action of new derivatives of tetrahydropirimidinedione-4,6.
Topics: Amphetamine; Analgesics; Animals; Brain; Chloral Hydrate; Drug Synergism; Female; Furans; Hexobarbital; Levodopa; Male; Mice; Movement; Pentylenetetrazole; Pyrimidinones; Reserpine; Seizures; Sleep | 1979 |
[Selective dopaminergic regulation of stereotyped forms of aggressive and defensive behavior].
Topics: Aggression; Amphetamine; Animals; Apomorphine; Behavior; Chinchilla; Dopamine; Humans; Levodopa; Rabbits; Stereotyped Behavior | 1977 |
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior | 1977 |
Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
Topics: Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Humans; Levodopa; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Substance Withdrawal Syndrome | 1978 |
[Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benserazide; Dopamine; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Methyltyrosines; Pimozide; Stereotyped Behavior | 1979 |
Experimental studies on hatching behavior in the chick. IV. Evidence for the role of a noradrenergic mechanism.
Topics: Amphetamine; Animals; Brain Chemistry; Catecholamines; Chick Embryo; Clonidine; Eggs; Heart Rate; Levodopa; Movement; Norepinephrine; Reserpine | 1978 |
Drug effect on cholinergic mechanisms in the cerebral cortex.
Topics: Acetylcholine; Amphetamine; Animals; Apomorphine; Cats; Cerebral Cortex; Chlorpromazine; Choline O-Acetyltransferase; Cholinergic Fibers; Levodopa; Nerve Endings; Rats; Receptors, Dopamine | 1978 |
Dopaminergic agonists in animal models of parkinsonism.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Cats; Disease Models, Animal; Haplorhini; Levodopa; Parkinson Disease, Secondary; Piribedil; Rats; Reserpine; Tyrosine | 1975 |
Parameters of alteration of pentobarbital response by hypothalamic polypeptides.
Topics: Amphetamine; Animals; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Male; Mice; Pentobarbital; Somatostatin; Temperature; Thyrotropin-Releasing Hormone; Tryptophan | 1975 |
Analysis of the mechanism of the protective activity of some sympathomimetic amines in experimental ulcers.
Topics: Amitriptyline; Amphetamine; Animals; Apomorphine; Butyrophenones; Catecholamines; Chlorpromazine; Cocaine; Levodopa; Morphine; Pimozide; Rats; Receptors, Adrenergic; Reserpine; Restraint, Physical; Stomach Ulcer; Sympathomimetics; Trifluperidol | 1977 |
The effect of amphetamine and L-dopa on tetrabenazine-induced suppression of intracranial self-stimulation in the rat.
Topics: Amphetamine; Animals; Depression, Chemical; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Levodopa; Male; Rats; Self Stimulation; Tetrabenazine | 1977 |
Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.
Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Levodopa; Male; Paranoid Disorders; Piribedil; Psychoses, Substance-Induced; Schizophrenia | 1977 |
Amphetamines, growth hormone and narcolepsy.
Topics: Adult; Aged; Amphetamine; Arousal; Clomipramine; Dextroamphetamine; Drug Interactions; Drug Tolerance; Female; Growth Hormone; Hemodynamics; Humans; Levodopa; Male; Methyldopa; Middle Aged; Narcolepsy; Time Factors | 1977 |
Is the release of noradrenaline necessary for self-stimulation of the brain?
Topics: Amphetamine; Animals; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Clonidine; Disulfiram; Levodopa; Male; Naphazoline; Nerve Endings; Norepinephrine; Oxymetazoline; Phenylephrine; Rats; Receptors, Drug; Reserpine; Self Stimulation | 1976 |
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra | 1976 |
Effects of catecholaminergic drugs on systems of reward and punishment in experiments on cats.
Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Benserazide; Catecholamines; Cats; Disulfiram; Electric Stimulation; Electrodes, Implanted; Levodopa; Male; Punishment; Reward | 1976 |
Effect of neuroleptic drugs on mouse jumping induced by L-DOPA in amphetamine treated mice.
Topics: Amphetamine; Animals; Behavior; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Levodopa; Male; Mice; Pimozide; Promethazine; Psychotropic Drugs; Stereotyped Behavior; Thioridazine; Tranquilizing Agents | 1976 |
[The pharmacologic basis of the antidepressive activity of the new psychotropic preparation pyrazidol].
Topics: 5-Hydroxytryptophan; Acetylcholine; Amphetamine; Animals; Antidepressive Agents; Arecoline; Blood Pressure; Cats; Dogs; Drug Synergism; Epinephrine; Gastrointestinal Motility; Hexobarbital; Indoles; Levodopa; Nicotine; Norepinephrine; Phenethylamines; Pyrazines; Rabbits; Rats; Reserpine; Tryptamines | 1975 |
Levodopa-induced myoclonus.
Topics: 5-Hydroxytryptophan; Aged; Amantadine; Amphetamine; Animals; Benztropine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Levodopa; Male; Methysergide; Middle Aged; Movement Disorders; Myoclonus; Parkinson Disease; Propranolol; Serotonin; Serotonin Antagonists; Sleep; Trihexyphenidyl | 1975 |
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1975 |
Differences between (+)- and (-)-amphetamine in effects on locomotor activity and L-dopa potentiating action in mice.
Topics: Amphetamine; Animals; Carbidopa; Carboxy-Lyases; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Levodopa; Motor Activity; Stereoisomerism; Time Factors | 1975 |
Narcotic withdrawal like mouse jumping produced by amphetamine and L-DOPA.
Topics: Amphetamine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Fluorometry; Haloperidol; Humans; Levodopa; Male; Mice; Motor Activity; Norepinephrine; Phentolamine; Pimozide; Substance Withdrawal Syndrome | 1975 |
Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Guinea Pigs; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Receptors, Drug; Stereotyped Behavior; Time Factors | 1975 |
Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Benztropine; Cyclazocine; Dopamine; Dose-Response Relationship, Drug; Humans; Levallorphan; Levodopa; Male; Motor Activity; Naloxone; Piribedil; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1975 |
The influence of piribedil (ET495) on components of locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Brain; Clonidine; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Motor Activity; Norepinephrine; Piperazines; Piribedil; Reserpine; Time Factors | 1975 |
Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanisms.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Catecholamines; Clonidine; Desipramine; Hydroxydopamines; Injections, Intraventricular; Levodopa; Male; Norepinephrine; Phenelzine; Rats | 1975 |
[Animal stereotypy and transmethylation of cerebral amines].
Topics: Amines; Amphetamine; Animals; Apomorphine; Brain; Levodopa; Movement Disorders; Piribedil; Rats; S-Adenosylmethionine | 1975 |
Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benztropine; Brain; Dopamine; Levodopa; Male; Rats; Stimulation, Chemical | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.
Topics: Amphetamine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Infusions, Intravenous; Levodopa; Male; Potassium; Rats; Rats, Sprague-Dawley; Reserpine | 1992 |
Oxidative ring-coupling of tyrosine and its derivatives by purified rat intestinal peroxidase.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Hydrogen Peroxide; Intestines; Kinetics; Levodopa; Mass Spectrometry; Methyltyrosines; Oxidation-Reduction; Peroxidases; Rats; Tyramine; Tyrosine | 1992 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Brain Tissue Transplantation; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Female; Fetal Tissue Transplantation; Levodopa; Male; Mesencephalon; Oxidopamine; Pregnancy; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Sympathectomy, Chemical | 1991 |
Dopamine uptake inhibition potentiates the effects of L-DOPA on rat substantia nigra zona compacta neurons.
Topics: Action Potentials; Amphetamine; Animals; Biological Transport; Cocaine; Dopamine; Dopamine Antagonists; Drug Synergism; Female; In Vitro Techniques; Levodopa; Male; Neurons; Neurotransmitter Uptake Inhibitors; Nomifensine; Rats; Rats, Inbred Strains; Substantia Nigra; Sulpiride | 1991 |
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Levodopa; Male; Rats; Selegiline | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
Further studies on the neuroleptic profile of manassantin A.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blepharoptosis; Body Temperature; Catalepsy; Furans; Haloperidol; In Vitro Techniques; Levodopa; Lignans; Male; Mice; Norepinephrine; Pentobarbital; Physostigmine; Plants, Medicinal; Stereotyped Behavior | 1990 |
Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine.
Topics: Aging; Amphetamine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Infusions, Parenteral; Levodopa; Male; Potassium; Rats; Rats, Inbred Strains; Reference Values | 1991 |
The effect of L-dopa and carbidopa on behavioural recovery produced by ventral mesencephalic grafts in rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Tissue Transplantation; Carbidopa; Corpus Striatum; Female; Fetal Tissue Transplantation; Hydroxydopamines; Levodopa; Mesencephalon; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1990 |
Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission.
Topics: Amphetamine; Animals; Brain; Dibenzocycloheptenes; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Ketamine; Levodopa; Male; Membrane Potentials; Mice; Phencyclidine; Rats; Rats, Inbred F344; Synaptic Transmission; Time Factors | 1990 |
[Functional and biochemical reorganization in hyperfunction of the dopaminergic system].
Topics: Acetylcholinesterase; Amphetamine; Animals; Brain; Cats; Dogs; Electroencephalography; Escape Reaction; Evoked Potentials, Visual; Levodopa; Monoamine Oxidase; Rabbits; Receptors, Dopamine | 1989 |
An in vivo pharmacological method for the quantitative evaluation of the central effects of alpha 1 adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamine; Animals; Apomorphine; Brain; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Male; Myoclonus; Nalidixic Acid; Naphthyridines; Rats; Rats, Inbred Strains; Stereoisomerism | 1986 |
Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Benztropine; Bupropion; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; Extracellular Space; Kinetics; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Rats; Rats, Inbred Strains | 1988 |
Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Corpus Striatum; Denervation; Dialysis; Dopamine; Extracellular Space; Hydroxydopamines; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Reference Values | 1986 |
Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and L-DOPA decarboxylase and monoamine oxidase inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Pargyline; Rabbits; Reserpine; Retina; Selegiline; Tyrosine | 1986 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
Circling behaviour in rats with unilateral lesions of the nigrostriatum induced by 6-hydroxydopamine: changes induced by oral administration of cytidine-5'-diphosphocholine.
Topics: Administration, Oral; Amphetamine; Animals; Apomorphine; Behavior, Animal; Choline; Corpus Striatum; Cytidine Diphosphate Choline; Hydroxydopamines; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1987 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoclopramide; Pentylenetetrazole; Rats | 1988 |
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
Dissociation of receptor sensitivity changes in rat perifornical hypothalamus: a role for dopaminergic receptors in amphetamine anorexic tolerance.
Topics: Amphetamine; Animals; Anorexia; Benserazide; Dextroamphetamine; Drug Tolerance; Eating; Feeding and Eating Disorders; Hypothalamus; Isoproterenol; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Pharmacological evidence of catecholaminergic involvement in the behavioral effects of luteinizing hormone releasing hormone in rats.
Topics: Amphetamine; Animals; Avoidance Learning; Catecholamines; Conditioning, Operant; Gonadotropin-Releasing Hormone; Levodopa; Male; Motor Activity; Rats; Rats, Inbred Strains | 1986 |
Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Disease Models, Animal; Ergolines; Levodopa; Lisuride; Male; Motor Activity; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1987 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Frontal Lobe; Haloperidol; Haplorhini; Levodopa; Mesencephalon; Methyltyrosines; Mice; Movement Disorders; Parkinson Disease; Posture; Rats; Reserpine; Substantia Nigra; Tegmentum Mesencephali; Thalamic Nuclei; Tremor | 1974 |
The psychiatrist attitudes and therapeutic means when faced with resistant depressions.
Topics: Amitriptyline; Amphetamine; Antidepressive Agents; Autistic Disorder; Depression; Drug Resistance; Drug Therapy, Combination; Humans; Imipramine; Levodopa; Lithium; Suicide; Thyrotropin-Releasing Hormone | 1974 |
Potentiation of jumping behavior by aminophylline in mice treated with threshold doses of amphentamine and dopa.
Topics: Aminophylline; Amphetamine; Animals; Behavior, Animal; Drug Synergism; Levodopa; Male; Mice; Motor Activity; Phentolamine; Pimozide; Stimulation, Chemical; Time Factors | 1974 |
Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Drinking Behavior; Electric Stimulation; Electromyography; Feeding and Eating Disorders; Feeding Behavior; Humans; Hydroxydopamines; Levodopa; Motor Neurons; Muscle Contraction; Nerve Degeneration; Neural Pathways; Parkinson Disease; Parkinson Disease, Secondary; Perceptual Disorders; Rats; Reflex, Stretch; Substantia Nigra | 1974 |
Effects of antihistaminic drugs in tests for antidepressant action.
Topics: Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Benserazide; Body Temperature; Histamine H1 Antagonists; Levodopa; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Reserpine | 1981 |
Role of the relationships between the neurotransmitter systems in the convulsive-seizure reactions.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Dopamine; Electroshock; gamma-Aminobutyric Acid; Kindling, Neurologic; Levodopa; Mice; Neurotransmitter Agents; Rats; Seizures; Serotonin | 1982 |
Effects of drug-induced changes in brain monoamines on aggression and motor behavior in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Aggression; Amphetamine; Animals; Biogenic Amines; Brain Chemistry; Diet; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Mice; Motor Activity; Tyrosine | 1984 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Drug-induced changes in motor activity after selective MAO inhibition.
Topics: Amphetamine; Animals; Brain; Clorgyline; Harmaline; Isoenzymes; Levodopa; Male; Mice; Monoamine Oxidase; Motor Activity; Pargyline; Phenethylamines; Propylamines | 1983 |
Effects of lithium on behaviour and central monoamines.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Catecholamines; Clonidine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Lithium; Locomotion; Mice; Motor Activity; Rats | 1980 |
The relationship between the stimulation of dopamine synthesis and release produced by amphetamine and high potassium in striatal slices.
Topics: Amphetamine; Animals; Calcium; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Egtazic Acid; Levodopa; Male; Potassium; Rats | 1980 |
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.
Topics: Amphetamine; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrogen-Ion Concentration; Levodopa; Methamphetamine; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline | 1982 |
Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Corpus Striatum; Humans; Hydroxydopamines; Levodopa; Male; Rats; Stereotyped Behavior; Substantia Nigra | 1980 |
Behavioural and biochemical changes following chronic administration of L-dopa to rats.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Catalepsy; Diet; Female; Humans; Levodopa; Motor Activity; Rats; Receptors, Dopamine; Stereotyped Behavior | 1982 |
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Brain; Cocaine; Dextroamphetamine; Dopamine; Feeding Behavior; Haloperidol; Levodopa; Methylphenidate; Rats; Spiperone | 1980 |
Synergistic induction of pineal gland N-acetyltransferase activity by amphetamine and L-DOPA.
Topics: Acetyltransferases; Amphetamine; Animals; Drug Synergism; Enzyme Induction; Levodopa; Male; Pineal Gland; Rats; Tyrosine | 1981 |
Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Topics: 4-Butyrolactone; Amphetamine; Animals; Carbidopa; Corpus Striatum; Dopamine; Electrochemistry; Haloperidol; Levodopa; Male; Pargyline; Rats; Rats, Inbred Strains | 1981 |
The role of dopaminergic and serotonergic mechanisms in the development of swimming ability of young rats.
Topics: Age Factors; Amphetamine; Animals; Animals, Newborn; Apomorphine; Haloperidol; Hydroxydopamines; Levodopa; Methysergide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Swimming; Tryptophan | 1981 |
Central action of ketotifen.
Topics: Amphetamine; Animals; Benserazide; Brain; Drug Interactions; Ketotifen; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Reserpine | 1981 |
[Avoidance reaction in rats following dopamine administration to the neostriatum].
Topics: Amphetamine; Animals; Avoidance Learning; Cats; Conditioning, Classical; Corpus Striatum; Dopamine; Levodopa; Male; Mice; Norepinephrine; Rats; Reaction Time; Serotonin; Species Specificity | 1980 |
Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
Topics: Amphetamine; Animals; Apomorphine; Brain Tissue Transplantation; Dihydroxyphenylalanine; Dopamine Agents; Dopamine Agonists; Dynorphins; Female; Fetal Tissue Transplantation; Image Processing, Computer-Assisted; Levodopa; Oxidopamine; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 1995 |
Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration.
Topics: Amphetamine; Animals; Apomorphine; Denervation; Immunohistochemistry; Levodopa; Male; Medial Forebrain Bundle; Movement; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Cell Compartmentation; Corpus Striatum; Dopamine; Drug Interactions; Levodopa; Male; Rats; Rats, Sprague-Dawley; Research Design; Reserpine; Secretory Rate | 1994 |
Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.
Topics: Amphetamine; Animals; Apomorphine; Body Weight; Immunohistochemistry; Levodopa; Male; Motor Activity; Nerve Fibers; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.
Topics: Amphetamine; Animals; Brain; Carbidopa; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Combinations; Functional Laterality; Immunohistochemistry; Levodopa; Male; Mesencephalon; Models, Neurological; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Tyrosine 3-Monooxygenase | 1994 |
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Topics: 4-Butyrolactone; Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Biogenic Monoamines; Brain; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Motor Activity; Perfusion; Potassium; Quinolines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Serotonin; Stereotyped Behavior; Synapses; Tetrahydronaphthalenes; Time Factors; Tritium | 1993 |
Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.
Topics: Amidines; Amphetamine; Animals; Behavior, Animal; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Clorgyline; Drug Interactions; Drug Synergism; Levodopa; Male; Methylation; Nitriles; Nitrophenols; Pyridones; Rats; Rats, Wistar; Tolcapone | 1993 |
Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
Topics: Amphetamine; Animals; Carrier Proteins; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred Strains; Nerve Tissue Proteins | 1996 |
Intranasal administration of the dopaminergic agonists L-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat.
Topics: Administration, Intranasal; Amphetamine; Animals; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Sodium Chloride | 1997 |
Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Extracellular Space; Levodopa; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley | 1996 |
Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Topics: Amphetamine; Animals; Brain; Cerebrovascular Circulation; Decarboxylation; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Levodopa; Macaca mulatta; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1997 |
Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carrier Proteins; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Fibers; Nerve Tissue Proteins; Neuropeptides; Neurotransmitter Agents; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Radioimmunoassay; Rats; Rats, Wistar; Substantia Nigra; Sulpiride; Sympatholytics; Tyrosine 3-Monooxygenase; Ventral Tegmental Area; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1998 |
Interaction between dopamine and glutamate in the sensorimotor cortex during conditioned placing reaction.
Topics: Amphetamine; Animals; Behavior, Animal; Cats; Conditioning, Classical; Dopamine; Glutamic Acid; Haloperidol; Levodopa; Male; Neocortex | 1998 |
Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Microdialysis; Motor Activity; Neostriatum; Neurons; Oxidopamine; Parkinson Disease, Secondary; Pergolide; Rats; Rats, Wistar | 1999 |
Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Apomorphine; Autoradiography; Carrier Proteins; Cocaine; Corpus Striatum; Cytoprotection; Dopamine Plasma Membrane Transport Proteins; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Tissue Proteins; Oligonucleotides, Antisense; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Nigra; Tritium | 2000 |
Disruption of acquisition and performance of operant response-duration differentiation by unilateral nigrostriatal lesions.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; Dopamine Agents; Histocytochemistry; Image Processing, Computer-Assisted; Levodopa; Male; Oxidopamine; Rats; Rats, Long-Evans; Reinforcement Schedule; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Sympathectomy, Chemical; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase | 2000 |
Pharmacological analysis of extracellular dopamine and metabolites in the striatum of conscious as/agu rats, mutants with locomotor disorder.
Topics: Amphetamine; Animals; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Extracellular Space; Levodopa; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Movement Disorders; Nomifensine; Potassium; Reference Values | 2000 |
Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Female; Forelimb; Hindlimb; Levodopa; Motor Activity; Motor Skills; Oxidopamine; Psychomotor Performance; Rats; Rats, Long-Evans; Rotation; Stereotyped Behavior; Substantia Nigra | 2002 |
Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism.
Topics: Amphetamine; Amphetamines; Animals; Cell Membrane; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Electrophysiology; gamma-Aminobutyric Acid; Levodopa; Mice; Mice, Inbred C57BL; Neurons; Quinpirole; Time Factors | 2003 |
Intracellular patch electrochemistry: regulation of cytosolic catecholamines in chromaffin cells.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Calibration; Catecholamines; Catechols; Cattle; Cells, Cultured; Central Nervous System Stimulants; Chromaffin Cells; Cytosol; Dopamine Agents; Electrochemistry; Homeostasis; Levodopa; Microelectrodes; Monoamine Oxidase Inhibitors; Pargyline; Patch-Clamp Techniques; Rats; Reserpine | 2003 |
Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Benzothiazoles; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Neuropeptides; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Thiazoles; Treatment Outcome; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2004 |
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease.
Topics: Adenosine A2 Receptor Antagonists; Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Levodopa; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Synapses; Triazoles | 2003 |
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Basal Ganglia; Behavior, Animal; Benzylamines; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Locus Coeruleus; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Statistics, Nonparametric; Tyrosine | 2004 |
Dysregulation of striatal dopamine signaling by amphetamine inhibits feeding by hungry mice.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Eating; Feeding and Eating Disorders; Feeding Behavior; Genetic Therapy; Hunger; Levodopa; Locomotion; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors; Tyrosine 3-Monooxygenase | 2004 |
Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding.
Topics: Amphetamine; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Eating; Feeding Behavior; Hypothalamus; Injections, Intraventricular; Levodopa; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Nomifensine; Signal Transduction; Tyrosine 3-Monooxygenase | 2005 |
Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Agents; AIDS-Related Complex; Amphetamine; Analgesics, Non-Narcotic; Animals; Antiparkinson Agents; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dynorphins; Dyskinesia, Drug-Induced; Functional Laterality; Homer Scaffolding Proteins; Immunohistochemistry; In Situ Hybridization; Levodopa; Male; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxidopamine; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2005 |
The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.
Topics: Amphetamine; Animals; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Female; Levodopa; Movement; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Substantia Nigra; Transplantation Tolerance | 2006 |
Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Risk Factors; Tyrosine 3-Monooxygenase | 2007 |
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Functional Laterality; Helplessness, Learned; Levodopa; Male; Nerve Degeneration; Neurons; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2007 |
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nervous System Stimulants; Citalopram; Dopamine Agents; Drinking; Dyskinesia, Drug-Induced; Image Processing, Computer-Assisted; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Sympatholytics; Synaptic Transmission | 2008 |
Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.
Topics: Adrenergic Agents; Amphetamine; Animals; Anti-Anxiety Agents; Behavior, Animal; Dextromethorphan; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Levodopa; Ligands; Male; N-Methylaspartate; Neurotoxicity Syndromes; Oxidopamine; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase.
Topics: Amphetamine; Animals; Basal Ganglia; Cocaine; Corpus Striatum; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Uptake Inhibitors; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Green Fluorescent Proteins; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Receptors, Dopamine D1 | 2008 |
Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism.
Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Benzothiazoles; Cabergoline; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Female; Levodopa; Mesencephalon; Oxidopamine; Parkinsonian Disorders; Pramipexole; Rats; Rats, Wistar; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 2008 |
The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.
Topics: Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dyskinesias; Histocompatibility Antigens Class II; Levodopa; Male; Microscopy, Electron, Transmission; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Synapses; Tissue Transplantation; Tyrosine 3-Monooxygenase | 2008 |
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Antiparkinson Agents; Brain Tissue Transplantation; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dyskinesias; Embryo, Mammalian; Encephalitis; Female; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Levodopa; Mesencephalon; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rats, Wistar; Skin Transplantation | 2008 |
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.
Topics: Amphetamine; Animals; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Corpus Striatum; Dopamine; Dyskinesias; Glutamine; Homovanillic Acid; Levodopa; Male; Morpholines; Naphthalenes; Oxidopamine; Rats; Rats, Wistar | 2009 |
Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesias; Embryo, Mammalian; Female; Levodopa; Mesencephalon; Oxidopamine; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Transplants; Tyrosine 3-Monooxygenase | 2009 |
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
Topics: Amphetamine; Animals; Antiparkinson Agents; Brain Tissue Transplantation; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Drug Synergism; Dyskinesia, Drug-Induced; Female; Levodopa; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Sympatholytics | 2009 |
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors.
Topics: Amphetamine; Analysis of Variance; Animals; Benserazide; Brain; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; In Situ Hybridization; Levodopa; Lipid Peroxidation; Male; Mice; Mice, Knockout; Motor Activity; Neurons; Oxidopamine; Receptor, Cannabinoid, CB1; Severity of Illness Index | 2011 |
Amphetamine reduces vesicular dopamine content in dexamethasone-differentiated PC12 cells only following L-DOPA exposure.
Topics: Amphetamine; Animals; Calcium; Cell Differentiation; Cell Survival; Chromaffin Cells; Dexamethasone; Dopamine; Dopamine Agents; Drug Interactions; Female; Glucocorticoids; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; PC12 Cells; Rats; Synaptic Vesicles | 2009 |
Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.
Topics: Amphetamine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Central Nervous System Stimulants; Cocaine; Conotoxins; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Male; Mecamylamine; Neostriatum; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Stereotyped Behavior | 2010 |
Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion.
Topics: Amphetamine; Animals; Bridged Bicyclo Compounds; Dopamine; Electric Stimulation; Excitatory Amino Acid Agonists; Extracellular Space; Levodopa; Locomotion; Male; Microdialysis; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate | 2010 |
Adrenochrome and related oxidative metabolites of catecholamines: effects on dopamine neurons and receptor binding profiles.
Topics: Action Potentials; Adrenochrome; Amphetamine; Animals; Catecholamines; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Indoles; Levodopa; Protein Binding; Rats; Receptors, Biogenic Amine; Ventral Tegmental Area | 2011 |
The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
Topics: Amphetamine; Animals; Behavior, Animal; Dyskinesias; Electrophysiology; Female; Ibotenic Acid; Levodopa; Locus Coeruleus; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2011 |
Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Intranasal; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Electrochemistry; Exploratory Behavior; Forelimb; Functional Laterality; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Motor Activity; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Sympatholytics | 2012 |
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Nervous System Diseases; Oxidopamine; Parkinson Disease, Secondary; Psychomotor Performance; Rats; Rats, Wistar; Sympatholytics; Walking | 2012 |
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Topics: alpha-Synuclein; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Behavioral Symptoms; Cell Count; Chromatography, High Pressure Liquid; Dependovirus; Disease Models, Animal; Disease Progression; Dopamine; Dopaminergic Neurons; ELAV Proteins; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Genetic Vectors; Green Fluorescent Proteins; Humans; Levodopa; Mesencephalon; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Rats; Rats, Sprague-Dawley; Regulatory Elements, Transcriptional; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2012 |
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study.
Topics: Amphetamine; Animals; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotation | 2012 |
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
Topics: 5,6-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Buspirone; Cell Count; Creatinine; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Receptor Agonists; Time Factors | 2012 |
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry.
Topics: Amphetamine; Animals; Central Nervous System; Central Nervous System Stimulants; Dopamine; Electrochemical Techniques; Female; Levodopa; Male; Mice; Mice, Inbred ICR; Particle Size; Reserpine; Synaptic Vesicles | 2013 |
The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease.
Topics: Administration, Oral; Amphetamine; Biological Availability; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline; Tablets | 2013 |
Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouse.
Topics: Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Cell Transplantation; Corpus Striatum; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Embryo, Mammalian; Functional Laterality; Levodopa; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Oxidopamine; Parkinson Disease; Stereotyped Behavior | 2012 |
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists | 2014 |
An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
Topics: Aged, 80 and over; Alzheimer Disease; Amphetamine; Dementia; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2014 |
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Adrenergic Neurons; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benzylamines; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Motor Activity; Nerve Degeneration; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Stereotyped Behavior | 2014 |
Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
Topics: Aging; Amphetamine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Embryo, Mammalian; Functional Laterality; Levodopa; Neurites; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred F344; Recovery of Function; Stem Cell Transplantation; Substance P | 2015 |
Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
Topics: Amphetamine; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Male; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Neurons; Oxidopamine; Parkinson Disease; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-fos; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2015 |
A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Amphetamine; Animals; Carbon; Carbon Fiber; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Electric Stimulation; Electrochemical Techniques; Extracellular Space; Levodopa; Microelectrodes; Pargyline; Rats, Wistar; Tissue Culture Techniques | 2015 |
DopAmide: Novel, Water-Soluble, Slow-Release l-dihydroxyphenylalanine (l-DOPA) Precursor Moderates l-DOPA Conversion to Dopamine and Generates a Sustained Level of Dopamine at Dopaminergic Neurons.
Topics: Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Rotation; Sympatholytics; Time Factors | 2016 |
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Choline O-Acetyltransferase; Cholinergic Neurons; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Functional Laterality; Genotype; Hypokinesia; Levodopa; Luminescent Proteins; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Optogenetics; Oxidopamine; Parkinson Disease; Receptor, Muscarinic M1; Receptor, Muscarinic M4; Transduction, Genetic | 2016 |
Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Levodopa; Male; Motor Activity; Nucleus Accumbens; Piperazines; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2017 |
Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Topics: Amphetamine; Animals; Antiparkinson Agents; Brain; Central Nervous System Stimulants; Dopamine; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Functional Laterality; Levodopa; Male; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurodegenerative Diseases; Oxidopamine; Parkinsonian Disorders; Receptors, Dopamine; Receptors, Nicotinic; RNA, Messenger | 2018 |
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; Forelimb; Gait Disorders, Neurologic; Interpersonal Relations; Levodopa; Locomotion; Male; Maze Learning; Memory Disorders; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2019 |
Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
Topics: Amphetamine; Animals; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Levodopa; Rats | 2022 |